Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma.

Cancer discovery·2023
Same author

Sequence and Structure-Based Analyses of Human Ankyrin Repeats.

Molecules (Basel, Switzerland)·2022
Same author

Meta-analysis of drought-tolerant genotypes in Oryza sativa: A network-based approach.

PloS one·2019
Same author

iCopyDAV: Integrated platform for copy number variations-Detection, annotation and visualization.

PloS one·2018

Related Experiment Video

Updated: Aug 9, 2025

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.8K

In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines.

Prashanthi Dharanipragada1, Nita Parekh1

  • 1Center for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad 500032, India.

Cells
|February 25, 2023
PubMed
Summary
This summary is machine-generated.

Whole-genome analysis of diffuse large B-cell lymphoma (DLBCL) reveals distinct genetic profiles and new subgroups. Findings suggest potential for genomics-driven precision treatments and novel patient stratification strategies.

Keywords:
cell linescopy number variationsdiffuse large B-cell lymphoma (DLBCL)precision medicinesequence variationsstructural variations

More Related Videos

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.4K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.8K

Related Experiment Videos

Last Updated: Aug 9, 2025

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.8K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.4K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.8K

Area of Science:

  • Genomics
  • Cancer Biology
  • Hematology

Background:

  • Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma, often driven by accumulating genetic variations.
  • Structural variations are increasingly recognized for their role in DLBCL genome instability and tumorigenesis.

Purpose of the Study:

  • To comprehensively analyze the whole-genome mutation profile of DLBCL cell lines.
  • To understand the genetic basis of DLBCL pathogenesis and identify potential therapeutic targets.

Main Methods:

  • Whole-genome sequencing of eleven human DLBCL cell lines (7 germinal-center B-cell-like, 4 activated B-cell-like).
  • Analysis of small sequence variants and large structural variations.
  • Validation using cBioPortal for Cancer Genomics annotations.

Main Results:

  • Distinct genetic variation profiles were observed across DLBCL cell lines, highlighting disease heterogeneity.
  • New subgroups were identified by combining genetic variations, linked to enriched pathways like PI3K-AKT and WNT signaling.
  • Mutation landscape analysis suggested drug-variant associations and potential treatment efficacies.

Conclusions:

  • DLBCL pathogenesis involves complex genetic variations, necessitating advanced patient stratification.
  • Genomic insights offer potential for developing precision treatments tailored to DLBCL subtypes and molecular profiles.